WLK · Westlake Corp
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| EBITDA non-GAAP | $679M | the three months ended June 30, 2026 filing | — |
|
|
|||
| EBITDA benefit from three-pillar profitability improvement plan non-GAAP | $150M | 2Q'26 | — |
| Free Cash Flow non-GAAP | $111M | Three months ended June 30, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Net cash provided by (used for) operating activities 318M
-207M Additions to property, plant and equipment
= Free cash flow 111M
|
|||
| Housing and Infrastructure Products EBITDA excl. Identified Items non-GAAP | $276M | 2Q 2026 | — |
|
|
|||
| Housing and Infrastructure Products EBITDA Margin non-GAAP | 22% | 2Q 2026 | — |
| Performance and Essential Materials EBITDA excl. Identified Items non-GAAP | $416M | 2Q 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Performance and Essential Materials EBITDA 416M
+0M Identified Items
= Performance and Essential Materials EBITDA excl. Identified Items 416M
|
|||
| Diluted loss per common share excl. Identified Items non-GAAP | -$0.77 | Three Months Ended March 31, 2026 | — |
| EBITDA excl. Identified Items non-GAAP | $235M | Three Months Ended March 31, 2026 | — |
|
|
|||
GAAP → non-GAAP reconciliationGAAP Income from operations excl. Identified Items $124M
+$60M Depreciation and amortization
+$2M Other income, net
= EBITDA excl. Identified Items $186M
|
|||
| EBITDA excl. Identified Items margin non-GAAP | 9% | 1Q'26 | — |
|
|
|||
| EBITDA margin excl. Identified Items non-GAAP | 9% | Three Months Ended March 31, 2026 | — |
| HIP EBITDA non-GAAP | $118M | Three Months Ended March 31, 2026 | — |
| HIP EBITDA excl. Identified Items non-GAAP | $186M | Three Months Ended March 31, 2026 | — |
| HIP EBITDA Margin non-GAAP | 19% | 1Q'26 | — |
| HIP Operating Income excl. Identified Items non-GAAP | $124M | Three Months Ended March 31, 2026 | — |
| Loss from operations excl. Identified Items non-GAAP | -$87M | Three Months Ended March 31, 2026 | — |
GAAP → non-GAAP reconciliationGAAP Loss from operations -172M
+85M Identified Items, pre-tax
= Loss from operations excl. Identified Items -87M
|
|||
| Net loss excl. Identified Items non-GAAP | -$88M | Three Months Ended March 31, 2026 | — |
| Operating loss margin excl. Identified Items non-GAAP | -3% | Three Months Ended March 31, 2026 | — |
| PEM EBITDA non-GAAP | 36M | 1Q'26 | — |
| PEM EBITDA excl. Identified Items non-GAAP | $36M | Three Months Ended March 31, 2026 | — |
| PEM EBITDA margin excl. Identified Items non-GAAP | 2% | Three Months Ended March 31, 2026 | — |
| PEM Loss from operations excl. Identified Items non-GAAP | -$194M | Three Months Ended March 31, 2026 | — |
| EBITDA margin | 10% | Twelve Months Ended December 31, 2025 | — |
| HIP Segment EBITDA | $823M | Twelve Months Ended December 31, 2025 | — |
| PEM Segment EBITDA | -$1.11B | Twelve Months Ended December 31, 2025 | — |
| PEM Segment EBITDA margin | 4% | Twelve Months Ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WLK
this stock
Westlake Corp
|
$9.68B | +2.4% | -8.0% | — | 3.9% |
|
LIN
Linde PLC
|
$225.65B | +14.8% | +3.0% | 31.6 | 1.1% |
|
AIQUF
L Air Liquide SA /Fi
|
$126.15B | +5.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.72B | +6.4% | +2.1% | 31.8 | 2.6% |
|
ECL
Ecolab Inc.
|
$80.38B | +9.2% | +2.2% | 38.5 | 1.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WLK | -4.1% | +7.4% | -28.8% | +7.4% | +2.4% |
| SPY | +0.5% | +3.0% | +13.4% | +3.0% | +12.8% |
| vs SPY | -4.6% | +4.4% | -42.2% | +4.4% | -10.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.